Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
9.82 Down 0.08(0.81%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development34,491  26,592  26,857  26,080  
Selling General and Administrative6,804  6,492  7,319  6,675  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (41,295) (33,084) (34,176) (32,755)
Income from Continuing Operations
Total Other Income/Expenses Net168  159  238  164  
Earnings Before Interest And Taxes(41,127)(32,925)(33,938)(32,591)
Interest Expense1,139   -   -   -  
Income Before Tax(42,266)(32,925)(33,938)(32,591)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(42,266)(32,925)(33,938)(32,591)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (42,266) (32,925) (33,938) (32,591)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (42,266) (32,925) (33,938) (32,591)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.